Article Figures & Data
Figures
- FIGURE 1.
Amino acid sequence of GRP and BN analogs. Common C-terminal 7 amino acids in GRP and BN analogs are indicated in boldface type.
- FIGURE 2.
Specific binding and internalization (dotted) of 111In-labeled BN analogs by GRP receptor-positive CA20948 (A) and AR42J (B) rat pancreatic tumor cells. 5° and 37° = 5°C and 37°C, respectively. Data are expressed as % dose per mg of protein.
- FIGURE 3.
Tissue distribution of 111In-labeled [DTPA-Pro1,Tyr4]BN, [DOTA-Pro1,Tyr4]BN, [DTPA-ε-Lys3,Tyr4]BN, and [DOTA-ε-Lys3,Tyr4]BN in rats 24 h after administration of radioligand. Nonspecific uptake of radioactivity (striped) was determined by coinjection of GRP receptor-blocking dose of 0.1 mg [Tyr4]BN. Difference between total uptake and nonspecific uptake represents specific binding of radioligand to GRP receptor. Data are expressed as %ID per gram of tissue and presented as means ± SD (n = 3).
- FIGURE 4.
Tissue-to-blood ratio of 111In-labeled [DTPA-Pro1,Tyr4]BN, [DOTA-Pro1,Tyr4]BN, [DTPA-ε-Lys3,Tyr4]BN, and [DOTA-ε-Lys3,Tyr4]BN in rats 24 h after administration of radioligand. Nonspecific uptake of radioactivity (striped) was determined by coinjection of GRP receptor-blocking dose of 0.1 mg [Tyr4]BN. Data are expressed as ratio of %ID per gram of tissue versus that in blood and presented as means ± SD (n = 3).
- FIGURE 5.
Distribution of radioactivity in AR42J tumor-bearing rat 24 h after administration of 15 MBq (0.1 μg) [111In-DOTA-Pro1,Tyr4]BN. Note uptake in tumor and physiologic uptake in kidneys.
In this issue
Jump to section
Related Articles
Cited By...
- Preparation and In Vitro and In Vivo Characterization of the Tumor-specific Antigen-derived Peptide as a Potential Candidate for Targeting Human Epidermal Growth Factor Receptor 2-positive Breast Carcinomas
- Targeted Radiotherapy of Prostate Cancer with a Gastrin-Releasing Peptide Receptor Antagonist Is Effective as Monotherapy and in Combination with Rapamycin
- In Vitro and In Vivo Evaluation of 64Cu-Labeled SarAr-Bombesin Analogs in Gastrin-Releasing Peptide Receptor-Expressing Prostate Cancer
- Design, Synthesis, Radiolabeling and In Vitro and In Vivo Characterization of Tumor-antigen- and Antibody-derived Peptides for the Detection of Breast Cancer
- International Union of Pharmacology. LXVIII. Mammalian Bombesin Receptors: Nomenclature, Distribution, Pharmacology, Signaling, and Functions in Normal and Disease States
- 177Lu-AMBA: Synthesis and Characterization of a Selective 177Lu-Labeled GRP-R Agonist for Systemic Radiotherapy of Prostate Cancer
- 111In-Benzyl-DTPA-ZHER2:342, an Affibody-Based Conjugate for In Vivo Imaging of HER2 Expression in Malignant Tumors
- Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression
- GRP Receptor-Targeted PET of a Rat Pancreas Carcinoma Xenograft in Nude Mice with a 68Ga-Labeled Bombesin(6-14) Analog
- 68Ga-Labeled Peptides in Tumor Imaging
- Increased Cell Death After Therapy with an Arg-Gly-Asp-Linked Somatostatin Analog
- Synthesis and Evaluation of Bombesin Derivatives on the Basis of Pan-Bombesin Peptides Labeled with Indium-111, Lutetium-177, and Yttrium-90 for Targeting Bombesin Receptor-Expressing Tumors
- microPET and Autoradiographic Imaging of GRP Receptor Expression with 64Cu-DOTA-[Lys3]Bombesin in Human Prostate Adenocarcinoma Xenografts